"ICON8:  Outcome in progression-free survival for weekly-dose paclitaxel in first-line ovarian cancer." (Click to go to Content)

• Attributon:

  • Ledermann J ICON8"  Outcome in progression-free survival for weekly-dose paclitaxel in first-line ovarian cancer.  https://www.youtube.com/watch?v=cy4Qxn5xUiU (9/2017)

  • VJOncology Youtube Channel:  https://www.youtube.com/channel/UCn3u5oMgE00_qIex2IzGjYg